Search

The reasons behind the decline in Cyberonics stocks are examined.

An FDA advisory panel voted to recommend that the federal agency approve the Cyberonics depression device. In Houston, a few Cyberonics insiders sold some of their stock when approval of the depression device appeared imminent.

Despite Wall Street's wariness about the health care industry under the upcoming Clinton administration, a Houston-based biotechnology company is headed for the stock market. Cyberonics Inc. developed and manufactures the [...]

The decision of Icahn Management LP fund to acquire stake in Cyberonics is discussed. The acquisition is attributed to the frequent increase and decrease in share prices of Cyberonics.

The impact of management issues on share price of Cyberonics Inc., despite U.S. Food and Drug Adminstration's autorizatioin to market pacemakers for chronic depression, is discussed.

Houston biotech company seeks to capitalize medical device for controlling epileptic seizures Cyberonics Inc., a Houston-area firm that developed an implantable medical device to control epileptic seizures, is making plans [...]